Mar 11, 2020 / 02:15PM GMT
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
Hi. Good morning, everybody, and thank you for joining us here for the Barclays Global Virtual Healthcare Conference. I am Kristen Stewart, the medical supplies and devices analyst here at Barclays. I'm very excited to have Johnson & Johnson here for this session.
Just as a reminder, if you want to ask any questions, you can e-mail me directly. You can also chat me on Bloomberg.
Before we kick it off with Ciro Roemer, who's the company group Chairman for Medical Devices in North America, I'm going to turn it over to Matt Stuckley, who's going to read some very riveting information for all of you. So make sure to pay attention. Matt?
Matthew Stuckley - Johnson & Johnson - Senior Director of IR
Thank you, Kristen, for that great introduction. So good morning, everyone.
Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular our 10-K, which discuss
Johnson & Johnson at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot